Edition:
United States

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

6.11USD
25 Sep 2018
Change (% chg)

$-0.51 (-7.70%)
Prev Close
$6.62
Open
$6.65
Day's High
$6.65
Day's Low
$5.98
Volume
212,324
Avg. Vol
172,867
52-wk High
$9.49
52-wk Low
$1.29

Select another date:

Mon, May 14 2018

BRIEF-Galectin Therapeutics Proceeds To Phase 3 Development Of GR-MD-02 For NASH Cirrhosis

* GALECTIN THERAPEUTICS PROCEEDS TO PHASE 3 DEVELOPMENT OF GR-MD-02 FOR NASH CIRRHOSIS FOLLOWING FDA MEETING

BRIEF-Galectin Therapeutics Q1 Loss Per Share $0.12

* GALECTIN THERAPEUTICS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Galectin Therapeutics Provides Business Update

* GALECTIN THERAPEUTICS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Select another date: